Delivery Order SPE2DB20D3103-SPE2DB25FP1R3

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,553.64, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The contract is a firm fixed-price delivery order, with a period of performance through May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit-dose packages of 30, with a ceiling value of $5,020.25. The contract is a firm fixed-price delivery order with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in units of 30, with a total ceiling value of $1,197.12. It is a Firm Fixed Price Delivery Order contract with a completion date of June 13, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime...
This is a $1,956.76 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in 30-count units. The contract has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. The company holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets, a medication used to treat hypertension. The contract is a firm fixed-price delivery order with a ceiling value of $10,006.35 and a period of performance through July 15, 2024. The contract was not set aside for any specific business...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,929.26, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of January 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count packages, with a ceiling value of $4,434.96 and a period of performance through May 6, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 80-25 mg tablets in 30-count units, with a ceiling value of $1,899.60 and a period of performance through May 5, 2025. The contract is not set aside and was awarded on May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract is a firm fixed-price delivery order with a ceiling value of $5,608.56 and a period of performance through January 27, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,507.44, is for the delivery of 4560843381 - Telmisartan-HCTZ 80-12.5 mg tablets in units of 30s. The contract has a firm fixed price and has a completion date of May 8, 2023. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP1R3
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in units of 30, with a ceiling value of $1,127.92. The contract is a firm fixed-price delivery order with a performance period extending through June 16, 2025. This order is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and the U.S. Coast Guard.

Generated 9/14/25, 12:52 AM